BENJAMIN AMBERG: Open Payments
NPI 1528545597 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 38 payments from 16 companies in 2025. Trend: 2023 $977 · 2024 $767 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $218 |
| PFIZER INC. | 4 | $96 |
| Dexcom, Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Abbott Laboratories | 2 | $41 |
| Stryker Corporation | 1 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $30 |
| Dynavax Technologies Corporation | 1 | $27 |
| Novo Nordisk Inc | 1 | $21 |
Products named: NURTEC ODT, VRAYLAR, UBRELVY, QULIPTA, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, FLOWTRIEVER CATHETER, S, XIFAXAN.
Industry payments across SC — which companies pay providers there.
